{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:27:15Z","timestamp":1789050435346,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U54AI170792"],"award-info":[{"award-number":["U54AI170792"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human herpesvirus (HHV) replication depends on the HHV protease (HHV Pr), an enzyme essential for capsid maturation. Because HHV Pr must transition from an inactive monomer to an active dimer, disrupting dimerization is a promising antiviral strategy. We isolate Fab5, a conformationally selective antibody from a na\u00efve Fab-phage library that recognizes monomeric human cytomegalovirus protease (HCMV) Pr. A 2.6\u2009\u00c5 cryo-EM structure reveals Fab5 binds a \u201clatch loop\u201d distal to the active site and dimer interface that secures the C-terminal tail in dimers. Structure-guided mutagenesis in both HCMV Pr and Kaposi\u2019s Sarcoma-associated herpesvirus (KSHV) Pr confirms the functional importance of a 3-residue motif present in \u03b2- and \u03b3-HHV Pr latch loops, validating the mechanistic role of the latch loop in dimerization and activity. Because the latch loop is structurally conserved in all HHV Prs, the cryptic sites they form present an avenue for allosteric inhibitor development.<\/jats:p>","DOI":"10.1038\/s41467-026-75438-2","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:13:19Z","timestamp":1783937599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibody reveals conformational latch regulating dimerization in \u03b2- and \u03b3-herpesvirus proteases"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1981-1244","authenticated-orcid":false,"given":"Marcell A.","family":"Zimanyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin R.","family":"Hulce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus-Frederik","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3194-689X","authenticated-orcid":false,"given":"Peter J.","family":"Rohweder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler C.","family":"Detomasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9535-0369","authenticated-orcid":false,"given":"Yifan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7704-9185","authenticated-orcid":false,"given":"Charles S.","family":"Craik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"75438_CR1","doi-asserted-by":"crossref","unstructured":"Arvin, A. et al. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. (Cambridge University Press, Cambridge, 2007).","DOI":"10.1017\/CBO9780511545313"},{"key":"75438_CR2","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1080\/21505594.2021.1982373","volume":"12","author":"S Zhu","year":"2021","unstructured":"Zhu, S. & Viejo-Borbolla, A. Pathogenesis and virulence of herpes simplex virus. Virulence 12, 2670\u20132702 (2021).","journal-title":"Virulence"},{"key":"75438_CR3","doi-asserted-by":"publisher","first-page":"538.e1","DOI":"10.1016\/j.jtct.2024.01.082","volume":"30","author":"P Chor\u00e3o","year":"2024","unstructured":"Chor\u00e3o, P. et al. Cytomegalovirus reactivations in allogeneic hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplantation cyclophosphamide. Transplant. Cell. Ther. 30, 538.e1\u2013538.e10 (2024).","journal-title":"Transplant. Cell. Ther."},{"key":"75438_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-024-05923-1","volume":"7","author":"E Egilmezer","year":"2024","unstructured":"Egilmezer, E., Hamilton, S. T., Foster, C. S. P., Marschall, M. & Rawlinson, W. D. Human cytomegalovirus (CMV) dysregulates neurodevelopmental pathways in cerebral organoids. Commun. Biol. 7, 1\u201312 (2024).","journal-title":"Commun. Biol."},{"key":"75438_CR5","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1021\/bi5003234","volume":"53","author":"JE Gable","year":"2014","unstructured":"Gable, J. E. et al. Broad-spectrum allosteric inhibition of herpesvirus proteases. Biochemistry 53, 4648 (2014).","journal-title":"Biochemistry"},{"key":"75438_CR6","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.clinthera.2018.07.006","volume":"40","author":"CL Poole","year":"2018","unstructured":"Poole, C. L. & James, S. H. Antiviral therapies for herpesviruses: current agents and new directions. Clin. Ther. 40, 1282\u20131298 (2018).","journal-title":"Clin. Ther."},{"key":"75438_CR7","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1128\/jvi.68.6.3702-3712.1994","volume":"68","author":"M Gao","year":"1994","unstructured":"Gao, M. et al. The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth. J. Virol. 68, 3702 (1994).","journal-title":"J. Virol."},{"key":"75438_CR8","doi-asserted-by":"publisher","first-page":"14831","DOI":"10.1073\/pnas.261560598","volume":"98","author":"W Dunn","year":"2001","unstructured":"Dunn, W., Trang, P., Khan, U., Zhu, J. & Liu, F. RNase P-mediated inhibition of cytomegalovirus protease expression and viral DNA encapsidation by oligonucleotide external guide sequences. Proc. Natl. Acad. Sci. USA 98, 14831\u201314836 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75438_CR9","doi-asserted-by":"publisher","first-page":"11382","DOI":"10.1021\/cr500255e","volume":"114","author":"JE Gable","year":"2014","unstructured":"Gable, J. E., Acker, T. M. & Craik, C. S. Current and potential treatments for ubiquitous but neglected herpesvirus infections. Chem. Rev. 114, 11382\u201311412 (2014).","journal-title":"Chem. Rev."},{"key":"75438_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/095632020001100101","volume":"11","author":"L Waxman","year":"2000","unstructured":"Waxman, L. & Darke, P. L. The herpesvirus proteases as targets for antiviral chemotherapy. Antivir. Chem. Chemother. 11, 1\u201322 (2000).","journal-title":"Antivir. Chem. Chemother."},{"key":"75438_CR11","doi-asserted-by":"publisher","first-page":"11650","DOI":"10.1021\/jacs.7b04030","volume":"139","author":"TM Acker","year":"2017","unstructured":"Acker, T. M. et al. Allosteric inhibitors, crystallography, and comparative analysis reveal network of coordinated movement across human herpesvirus proteases. J. Am. Chem. Soc. 139, 11650\u201311653 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"75438_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/jm0102203","volume":"45","author":"AD Borthwick","year":"2002","unstructured":"Borthwick, A. D. et al. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-Oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. potency and chirality. J. Med. Chem. 45, 1\u201318 (2002).","journal-title":"J. Med. Chem."},{"key":"75438_CR13","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/nsb0901-810","volume":"8","author":"R Batra","year":"2001","unstructured":"Batra, R., Khayat, R. & Tong, L. Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease. Nat. Struct. Biol. 8, 810\u2013817 (2001).","journal-title":"Nat. Struct. Biol."},{"key":"75438_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1021\/bi027045s","volume":"42","author":"R Khayat","year":"2003","unstructured":"Khayat, R. et al. Structural and biochemical studies of inhibitor binding to human cytomegalovirus protease. Biochemistry 42, 885\u2013891 (2003).","journal-title":"Biochemistry"},{"key":"75438_CR15","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1128\/JVI.02663-10","volume":"85","author":"SM Fernandes","year":"2011","unstructured":"Fernandes, S. M., Brignole, E. J., Taori, K. & Gibson, W. Cytomegalovirus capsid protease: biological substrates are cleaved more efficiently by full-length enzyme (pUL80a) than by the catalytic domain (assemblin). J. Virol. 85, 3526\u20133534 (2011).","journal-title":"J. Virol."},{"key":"75438_CR16","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/nsmb1006","volume":"12","author":"AM Nomura","year":"2005","unstructured":"Nomura, A. M., Marnett, A. B., Shimba, N., D\u00f6tsch, V. & Craik, C. S. Induced structure of a helical switch as a mechanism to regulate enzymatic activity. Nat. Struct. Mol. Biol. 12, 1019\u20131020 (2005).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"75438_CR17","doi-asserted-by":"publisher","first-page":"6870","DOI":"10.1073\/pnas.0401613101","volume":"101","author":"AB Marnett","year":"2004","unstructured":"Marnett, A. B., Nomura, A. M., Shimba, N., Ortiz de Montellano, P. R. & Craik, C. S. Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor. Proc. Natl. Acad. Sci. USA 101, 6870\u20136875 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75438_CR18","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jmb.2011.06.032","volume":"411","author":"GM Lee","year":"2011","unstructured":"Lee, G. M., Shahian, T., Baharuddin, A., Gable, J. E. & Craik, C. S. Enzyme inhibition by allosteric capture of an inactive conformation. J. Mol. Biol. 411, 999\u20131016 (2011).","journal-title":"J. Mol. Biol."},{"key":"75438_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jmb.2008.05.009","volume":"380","author":"CJ Farady","year":"2008","unstructured":"Farady, C. J., Egea, P. F., Schneider, E. L., Darragh, M. R. & Craik, C. S. Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition. J. Mol. Biol. 380, 351\u2013360 (2008).","journal-title":"J. Mol. Biol."},{"key":"75438_CR20","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1110\/ps.8.12.2686","volume":"8","author":"J Lescar","year":"1999","unstructured":"Lescar, J. et al. Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody. Protein Sci. Publ. Protein Soc. 8, 2686 (1999).","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"75438_CR21","first-page":"3165","volume":"176","author":"Y Fukuoka","year":"2006","unstructured":"Fukuoka, Y. & Schwartz, L. B. The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized \u03b2-tryptase to form monomers that are inactive at neutral pH and active at acidic pH. J. Immunol. Baltim. Md 1950 176, 3165 (2006).","journal-title":"J. Immunol. Baltim. Md 1950"},{"key":"75438_CR22","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1016\/j.jmb.2019.09.008","volume":"431","author":"M Schaefer","year":"2019","unstructured":"Schaefer, M., Buchmueller, A., Dittmer, F., Stra\u00dfburger, J. & Wilmen, A. Allosteric inhibition as a new mode of action for BAY 1213790, a neutralizing antibody targeting the activated form of coagulation factor XI. J. Mol. Biol. 431, 4817\u20134833 (2019).","journal-title":"J. Mol. Biol."},{"key":"75438_CR23","doi-asserted-by":"publisher","first-page":"14023","DOI":"10.1021\/bi9712697","volume":"36","author":"SS Hoog","year":"1997","unstructured":"Hoog, S. S. et al. Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease\/inhibitor complex. Biochemistry 36, 14023\u201314029 (1997).","journal-title":"Biochemistry"},{"key":"75438_CR24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/1860","volume":"5","author":"L Tong","year":"1998","unstructured":"Tong, L. et al. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease. Nat. Struct. Biol. 5, 819\u2013826 (1998).","journal-title":"Nat. Struct. Biol."},{"key":"75438_CR25","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/nchembio.192","volume":"5","author":"T Shahian","year":"2009","unstructured":"Shahian, T. et al. Inhibition of a viral enzyme by a small-molecule dimer disruptor. Nat. Chem. Biol. 5, 640\u2013646 (2009).","journal-title":"Nat. Chem. Biol."},{"key":"75438_CR26","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1021\/acsmedchemlett.3c00359","volume":"14","author":"S Yoshida","year":"2023","unstructured":"Yoshida, S. et al. Peptide-to-small molecule: discovery of non-covalent, active-site inhibitors of \u03b2-herpesvirus proteases. ACS Med. Chem. Lett. 14, 1558\u20131566 (2023).","journal-title":"ACS Med. Chem. Lett."},{"key":"75438_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ymeth.2011.09.012","volume":"55","author":"J Kim","year":"2011","unstructured":"Kim, J., Stroud, R. M. & Craik, C. S. Rapid identification of recombinant Fabs that bind to membrane proteins. Methods 55, 303\u2013309 (2011).","journal-title":"Methods"},{"key":"75438_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2020.140562","volume":"1869","author":"N Sevillano","year":"2021","unstructured":"Sevillano, N. et al. Structure of an affinity-matured inhibitory recombinant fab against urokinase plasminogen activator reveals basis of potency and specificity. Biochim. Biophys. Acta Proteins Proteomics 1869, 140562 (2021).","journal-title":"Biochim. Biophys. Acta Proteins Proteomics"},{"key":"75438_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.chembiol.2022.03.007","volume":"29","author":"KR Hulce","year":"2022","unstructured":"Hulce, K. R. et al. Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine. Cell Chem. Biol. 29, 785\u2013798.e19 (2022).","journal-title":"Cell Chem. Biol."},{"key":"75438_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.sbi.2020.05.007","volume":"64","author":"M Wu","year":"2020","unstructured":"Wu, M. & Lander, G. C. How low can we go? Structure determination of small biological complexes using single-particle cryo-EM. Curr. Opin. Struct. Biol. 64, 9\u201316 (2020).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"75438_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.copbio.2019.01.012","volume":"60","author":"K Basu","year":"2019","unstructured":"Basu, K., Green, E. M., Cheng, Y. & Craik, C. S. Why recombinant antibodies \u2014 benefits and applications. Curr. Opin. Biotechnol. 60, 153\u2013158 (2019).","journal-title":"Curr. Opin. Biotechnol."},{"key":"75438_CR32","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.1016\/j.cell.2024.08.036","volume":"187","author":"M Jin","year":"2024","unstructured":"Jin, M. et al. Dynamic allostery drives autocrine and paracrine TGF-\u03b2 signaling. Cell 187, 6200\u20136219 (2024).","journal-title":"Cell"},{"key":"75438_CR33","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/prot.26307","volume":"90","author":"D Bern","year":"2022","unstructured":"Bern, D. & Tobi, D. The effect of dimerization and ligand binding on the dynamics of Kaposi\u2019s sarcoma-associated herpesvirus protease. Proteins 90, 1267 (2022).","journal-title":"Proteins"},{"key":"75438_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abp9159","volume":"14","author":"J Chavarria-Smith","year":"2022","unstructured":"Chavarria-Smith, J. et al. Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis. Sci. Transl. Med. 14, eabp9159 (2022).","journal-title":"Sci. Transl. Med."},{"key":"75438_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11095-018-2554-7","volume":"36","author":"GA Rodrigues","year":"2018","unstructured":"Rodrigues, G. A. et al. Pharmaceutical development of AAV-based gene therapy products for the eye. Pharm. Res. 36, 29 (2018).","journal-title":"Pharm. Res."},{"key":"75438_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40580-023-00385-3","volume":"10","author":"J Han","year":"2023","unstructured":"Han, J. et al. Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy. Nano Converg 10, 36 (2023).","journal-title":"Nano Converg"},{"key":"75438_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202317817","volume":"63","author":"P Chen","year":"2024","unstructured":"Chen, P. et al. Selective intracellular delivery of antibodies in cancer cells with nanocarriers sensing endo\/lysosomal enzymatic activity. Angew. Chem. Int. Ed. 63, e202317817 (2024).","journal-title":"Angew. Chem. Int. Ed."},{"key":"75438_CR38","doi-asserted-by":"publisher","first-page":"26878","DOI":"10.1074\/jbc.M109.077677","volume":"285","author":"S Duriseti","year":"2010","unstructured":"Duriseti, S. et al. Antagonistic anti-urokinase plasminogen activator receptor (uPAR) antibodies significantly inhibit uPAR-mediated cellular signaling and migration *. J. Biol. Chem. 285, 26878\u201326888 (2010).","journal-title":"J. Biol. Chem."},{"key":"75438_CR39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"75438_CR40","doi-asserted-by":"publisher","unstructured":"Asarnow, D., Palovcak, E. & Cheng, Y. asarnow\/pyem: UCSF pyem v0.5. Zenodohttps:\/\/doi.org\/10.5281\/zenodo.3576630 (2019).","DOI":"10.5281\/zenodo.3576630"},{"key":"75438_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"TI Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. Sect. Struct. Biol. 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr. Sect. Struct. Biol."},{"key":"75438_CR42","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. Sect. Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. Sect. Struct. Biol."},{"key":"75438_CR43","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"75438_CR44","doi-asserted-by":"publisher","first-page":"168018","DOI":"10.1016\/j.jmb.2023.168018","volume":"435","author":"N Oberg","year":"2023","unstructured":"Oberg, N., Zallot, R. & Gerlt, J. A. EFI-EST, EFI-GNT, and EFI-CGFP: Enzyme Function Initiative (EFI) Web Resource for Genomic Enzymology Tools. J. Mol. Biol. 435, 168018 (2023).","journal-title":"J. Mol. Biol."},{"key":"75438_CR45","doi-asserted-by":"publisher","first-page":"W521","DOI":"10.1093\/nar\/gkae241","volume":"52","author":"F Madeira","year":"2024","unstructured":"Madeira, F. et al. The EMBL-EBI Job Dispatcher sequence analysis tools framework in 2024. Nucleic Acids Res. 52, W521\u2013W525 (2024).","journal-title":"Nucleic Acids Res."},{"key":"75438_CR46","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1101\/gr.849004","volume":"14","author":"GE Crooks","year":"2004","unstructured":"Crooks, G. E., Hon, G., Chandonia, J.-M. & Brenner, S. E. WebLogo: a sequence logo generator. Genome Res. 14, 1188\u20131190 (2004).","journal-title":"Genome Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75438-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75438-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75438-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T22:43:35Z","timestamp":1787093015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75438-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75438"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75438-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.C. is a non-shareholder member of the scientific advisory boards for ShuiMu BioSciences and Pamplona Therapeutic Co. M.A.Z., K.R.H., M.F.B., J.N., P.J.R., T.C.D., and C.S.C. declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8590"}}